Bausch + Lomb Corporation (NYSE: BLCO)
Health Care · Health Care Equipment & Supplies · CA
$15.77
-8.84% today · +20.0% 1Y
Bausch + Lomb Corporation (NYSE: BLCO) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $6.18B and employs 13,000 people.
Over the last twelve months the share price has gained 20.0%, trading between 13.77 and 18.92.
Tweenvest scores Bausch + Lomb Corporation across four factors: quality 61/100, value 75/100, growth 34/100. Its strongest factor is value.
BLCO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.18B
- Revenue (TTM)
- $5.32B
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- $18.92
- 52-week low
- $13.77
- Avg volume (3M)
- —
- Shares outstanding
- 357.17M
- Employees
- 13,000
- Next earnings
- —
About Bausch + Lomb Corporation
Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options. This segment also provides essential contact lens care products, over-the-counter eye drops, and nutritional supplements aimed at alleviating common eye conditions like allergies, conjunctivitis, and dry eye. Through its Ophthalmic Pharmaceuticals segment, the company develops and markets both proprietary and generic prescription medications. These pharmaceuticals are utilized for post-operative recovery and the treatment of various ocular diseases, such as glaucoma, ocular hypertension, and retinal disorders. Additionally, it supplies therapeutic contact lenses. The Surgical segment is dedicated to providing advanced tools and technologies for surgical interventions related to cataracts, as well as vitreous and retinal conditions. Its offerings include intraocular lenses (IOLs) with their delivery systems, phacoemulsification equipment, and a range of other specialized surgical instruments and devices. Founded in 1853, Bausch + Lomb is headquartered in Vaughan, Canada.
- ISIN
- CA0717051076
- Founded
- 1853
- Listed since
- May 6, 2022
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Insulet CorporationNasdaqGS: PODD | $9.38B | $137.90 | +1.94% |
| Sysmex CorporationTSE: 6869 | $7.09B | ¥1,855.00 | -1.43% |
| Getinge AB (publ)OM: GETI B | $6.90B | Skr253.20 | +2.76% |
| Lantheus Holdings, Inc.NasdaqGM: LNTH | $6.54B | $100.21 | +0.06% |
| Shenzhen New Industries Biomedical Engineering Co., Ltd.SZSE: 300832 | $5.92B | CN¥50.50 | +3.31% |
| Cochlear LimitedASX: COH | $5.86B | AU$128.39 | -0.47% |
| Ypsomed Holding AGSWX: YPSN | $5.73B | CHF359.60 | -0.72% |
| Convatec Group PLCLSE: CTEC | $5.69B | £2.31 | +4.82% |
Figures last refreshed Oct 11, 2026.